Search
VB2-011
go.drugbank.com/drugs/DB05411ExperimentalVB2-011 is an antibody developed as an anti-cancer treatment. According to some preclinical studies, it has a potential to inhibit tumour growth in various cancers including lymphoma and melanoma. … This drug includes the parent IgM (H11 IgM) and a recombinant IgG version (H11 IgG).
Thalagen
go.drugbank.com/drugs/DB17714ExperimentalIt is being investigated for the treatment of beta-thalassemia.[L46168] … Thalagen is a branded product developed by San Rocco Therapeutics.
AVR-RD-05
go.drugbank.com/drugs/DB18631ExperimentalIt is under investigation for the treatment of Hunter Syndrome (Mucopolysaccharidosis Type II, MPSII). … AVR-RD-05 is a gene therapy comprising genetically modified autologous stem cells transduced _ex vivo_ with a lentiviral vector encoding the human iduronate-2-sulfatase (IDS) enzyme.
Synonyms: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndromeFumaric acid
go.drugbank.com/drugs/DB01677InvestigationalSynonyms: (E)-2-butenedioic acidCategories: Antipsoriatics for Topical UseSulfamethoxypyridazine
go.drugbank.com/drugs/DB13773InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseOmoconazole
go.drugbank.com/drugs/DB13684ExperimentalCategories: Antifungals for Topical Use, Antifungals for Dermatological UseSulbenicillin
go.drugbank.com/drugs/DB13693InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseMesoheme
go.drugbank.com/drugs/DB02577ExperimentalIt is found free in tissues and as the prosthetic group in many hemeproteins.
Categories: Heterocyclic Compounds with 4 or More RingsDiloxanide furoate
go.drugbank.com/drugs/DB14638ApprovedInvestigationalSynonyms: 2,2-dichloroacetamido-4-n-methylphenyl 2-furoate, 4-(n-methyl-2,2-dichloroacetamido)phenyl 2-furoateSR-9009
go.drugbank.com/drugs/DB14013ExperimentalSR-9009 is a REV-ERB agonist. … SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues